Back to top
more

Lannett Co Inc (LCI)

(Delayed Data from NYSE)

$8.54 USD

8.54
1,487,457

+0.70 (8.93%)

Updated May 3, 2019 04:00 PM ET

After-Market: $8.54 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[LCI]

Reports for Purchase

Showing records 161 - 180 ( 421 total )

Industry: Medical - Drugs

Record: 161

05/19/2015

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 162

05/19/2015

Daily Note

Pages: 4

Quick Take on Silarx

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 163

05/19/2015

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 164

05/18/2015

Company Report

Pages: 7

Digoxin/Levo Tracker - Week ending 5/8/2015

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 165

05/08/2015

Company Report

Pages: 7

Digoxin/Levo Tracker - Week ending 5/1/2015

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 166

05/08/2015

Daily Note

Pages: 3

MORNING - MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 167

05/07/2015

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 168

05/07/2015

Company Report

Pages: 6

FY3Q15 Results - Within Expectations

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 169

05/01/2015

Daily Note

Pages: 5

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 170

05/01/2015

Company Report

Pages: 7

Digoxin/Levo Tracker - Week ending 4/24/2015

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 171

04/29/2015

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 172

04/29/2015

Company Report

Pages: 7

Digoxin/Levo Tracker - Week ending 4/17/2015

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 173

04/20/2015

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 174

04/17/2015

Daily Note

Pages: 4

Digoxin Monthly Tracker (March 2015)

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 175

04/17/2015

Company Report

Pages: 7

Digoxin/Levo Tracker - Week ending 4/10/2015

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 176

04/17/2015

Daily Note

Pages: 4

Levo Monthly Tracker (March 2015)

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 177

04/10/2015

Company Report

Pages: 7

Digoxin/Levo Tracker - Week ending 4/3/2015

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 178

04/06/2015

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 179

04/06/2015

Company Report

Pages: 7

Digoxin/Levo Tracker - Week ending 3/27/2015

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 180

03/30/2015

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party
// eof